Chinese General Practice ›› 2025, Vol. 28 ›› Issue (24): 2972-2978.DOI: 10.12114/j.issn.1007-9572.2024.0515
• Article • Previous Articles Next Articles
Received:
2025-01-10
Revised:
2025-04-15
Published:
2025-08-20
Online:
2025-06-23
Contact:
HE Yan
通讯作者:
何燕
作者简介:
作者贡献:
魏云鸿提出研究思路,设计研究方案,负责研究资料的收集与整理、论文撰写;杨莉负责论文修订、文章的质量控制及审校;王玉路负责研究资料以及各项数据的收集整理及统计学分析;叶秋芳、代安妮负责数据的校对、表格及图片的编辑与整理;何燕负责文章的构思与设计,最终版本修订,对文章整体负责。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0515
组别 | 例数 | 性别[例(%)] | 年龄(岁) | 身高(cm) | 体质量(kg) | BMI(kg/m2) | HDL-C(mmol/L) | LDL-C(mmol/L) | TC(mmol/L) | TG(mmol/L) | FBG(mmol/L) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
女 | 男 | |||||||||||
对照组 | 209 | 110(52.63) | 99(47.37) | 51±11 | 164.66±8.37 | 60.06±7.55 | 22.06±1.34 | 1.24±0.29 | 2.91±0.78 | 4.81±0.94 | 1.70±1.01 | 5.43±1.08 |
超重高血压组 | 210 | 72(34.29)a | 138(65.71)a | 49±10 | 166.30±7.85 | 71.20±7.78a | 25.66±1.05a | 1.10±0.26a | 2.85±0.77 | 4.74±0.94 | 2.30±2.11a | 5.75±1.91 |
肥胖高血压组 | 206 | 64(31.07)ab | 142(68.93)ab | 46±11ab | 167.20±9.37a | 85.20±11.71ab | 30.40±2.24ab | 1.06±0.26a | 2.94±0.78 | 4.82±0.92 | 2.53±1.74a | 5.60±1.05 |
F(χ2)值 | 23.623c | 12.994 | 4.710 | 388.764 | 1 379.921 | 27.537 | 0.790 | 0.472 | 13.544 | 2.783 | ||
P值 | <0.001 | <0.001 | 0.009 | <0.001 | <0.001 | <0.001 | 0.454 | 0.624 | <0.001 | 0.063 |
Table 1 Comparison of general data among three groups
组别 | 例数 | 性别[例(%)] | 年龄(岁) | 身高(cm) | 体质量(kg) | BMI(kg/m2) | HDL-C(mmol/L) | LDL-C(mmol/L) | TC(mmol/L) | TG(mmol/L) | FBG(mmol/L) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
女 | 男 | |||||||||||
对照组 | 209 | 110(52.63) | 99(47.37) | 51±11 | 164.66±8.37 | 60.06±7.55 | 22.06±1.34 | 1.24±0.29 | 2.91±0.78 | 4.81±0.94 | 1.70±1.01 | 5.43±1.08 |
超重高血压组 | 210 | 72(34.29)a | 138(65.71)a | 49±10 | 166.30±7.85 | 71.20±7.78a | 25.66±1.05a | 1.10±0.26a | 2.85±0.77 | 4.74±0.94 | 2.30±2.11a | 5.75±1.91 |
肥胖高血压组 | 206 | 64(31.07)ab | 142(68.93)ab | 46±11ab | 167.20±9.37a | 85.20±11.71ab | 30.40±2.24ab | 1.06±0.26a | 2.94±0.78 | 4.82±0.92 | 2.53±1.74a | 5.60±1.05 |
F(χ2)值 | 23.623c | 12.994 | 4.710 | 388.764 | 1 379.921 | 27.537 | 0.790 | 0.472 | 13.544 | 2.783 | ||
P值 | <0.001 | <0.001 | 0.009 | <0.001 | <0.001 | <0.001 | 0.454 | 0.624 | <0.001 | 0.063 |
组别 | 例数 | 静止期 | 无氧阈 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SBP(mmHg) | DBP(mmHg) | HR(次/min) | VO2(mL/min) | VO2% | VO2/kg | HR(次/min) | ||||||
对照组 | 209 | 138±19 | 88±12 | 80.76±15.32 | 933.44±259.83 | 54.26±13.74 | 15.63±3.57 | 120.38±18.94 | ||||
超重高血压组 | 210 | 136±18 | 88±11 | 81.63±11.87 | 1 043.67±266.89a | 51.18±13.60a | 14.71±3.11a | 118.54±16.68 | ||||
肥胖高血压组 | 206 | 140±19 | 90±13 | 83.93±13.57 | 1 165.58±278.19ab | 50.12±12.56ab | 13.67±2.83ab | 119.27±15.87 | ||||
F值 | 0.904 | 1.849 | 2.979 | 38.841 | 5.445 | 19.666 | 0.603 | |||||
P值 | 0.405 | 0.158 | 0.052 | <0.001 | 0.005 | <0.001 | 0.547 | |||||
组别 | 运动高峰期 | |||||||||||
SBP(mmHg) | DBP(mmHg) | VO2(mL/min) | VO2% | VO2/kg | HR(次/min) | HR% | O2 pulse | RER | BR% | ΔVO2/ΔWR | VE/VCO2 slope | |
对照组 | 196±22 | 99±17 | 1 372.15±359.77 | 79.16±15.89 | 22.80±4.62 | 150.69±16.80 | 89.01±8.36 | 9.13±2.04 | 1.12±0.08 | 53.45±12.09 | 10.47±1.81 | 29.52±4.91 |
超重高血压组 | 204±23a | 97±16 | 1 536.58±373.83a | 74.60±13.68a | 21.51±3.89a | 148.61±18.97 | 87.55±8.24 | 10.36±2.18a | 1.13±0.08 | 51.54±11.92 | 10.19±1.84 | 29.38±4.63 |
肥胖高血压组 | 201±25a | 98±16 | 1 634.19±380.58ab | 69.25±15.43ab | 19.17±3.73ab | 144.07±18.79ab | 82.65±9.26ab | 11.78±2.81ab | 1.10±0.08ab | 48.87±12.54a | 10.26±2.16 | 29.17±5.27 |
F值 | 5.806 | 0.820 | 26.411 | 22.597 | 41.687 | 9.150 | 30.944 | 25.762 | 5.066 | 7.414 | 1.190 | 0.260 |
P值 | 0.003 | 0.441 | <0.001 | <0.001 | <0.001 | 0.001 | <0.001 | 0.001 | 0.007 | <0.001 | 0.305 | 0.771 |
Table 2 Comparison of the indicators among resting phase,anaerobic threshold and peak exercise in CPET
组别 | 例数 | 静止期 | 无氧阈 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SBP(mmHg) | DBP(mmHg) | HR(次/min) | VO2(mL/min) | VO2% | VO2/kg | HR(次/min) | ||||||
对照组 | 209 | 138±19 | 88±12 | 80.76±15.32 | 933.44±259.83 | 54.26±13.74 | 15.63±3.57 | 120.38±18.94 | ||||
超重高血压组 | 210 | 136±18 | 88±11 | 81.63±11.87 | 1 043.67±266.89a | 51.18±13.60a | 14.71±3.11a | 118.54±16.68 | ||||
肥胖高血压组 | 206 | 140±19 | 90±13 | 83.93±13.57 | 1 165.58±278.19ab | 50.12±12.56ab | 13.67±2.83ab | 119.27±15.87 | ||||
F值 | 0.904 | 1.849 | 2.979 | 38.841 | 5.445 | 19.666 | 0.603 | |||||
P值 | 0.405 | 0.158 | 0.052 | <0.001 | 0.005 | <0.001 | 0.547 | |||||
组别 | 运动高峰期 | |||||||||||
SBP(mmHg) | DBP(mmHg) | VO2(mL/min) | VO2% | VO2/kg | HR(次/min) | HR% | O2 pulse | RER | BR% | ΔVO2/ΔWR | VE/VCO2 slope | |
对照组 | 196±22 | 99±17 | 1 372.15±359.77 | 79.16±15.89 | 22.80±4.62 | 150.69±16.80 | 89.01±8.36 | 9.13±2.04 | 1.12±0.08 | 53.45±12.09 | 10.47±1.81 | 29.52±4.91 |
超重高血压组 | 204±23a | 97±16 | 1 536.58±373.83a | 74.60±13.68a | 21.51±3.89a | 148.61±18.97 | 87.55±8.24 | 10.36±2.18a | 1.13±0.08 | 51.54±11.92 | 10.19±1.84 | 29.38±4.63 |
肥胖高血压组 | 201±25a | 98±16 | 1 634.19±380.58ab | 69.25±15.43ab | 19.17±3.73ab | 144.07±18.79ab | 82.65±9.26ab | 11.78±2.81ab | 1.10±0.08ab | 48.87±12.54a | 10.26±2.16 | 29.17±5.27 |
F值 | 5.806 | 0.820 | 26.411 | 22.597 | 41.687 | 9.150 | 30.944 | 25.762 | 5.066 | 7.414 | 1.190 | 0.260 |
P值 | 0.003 | 0.441 | <0.001 | <0.001 | <0.001 | 0.001 | <0.001 | 0.001 | 0.007 | <0.001 | 0.305 | 0.771 |
组别 | 例数 | LVEDd(mm) | IVST(mm) | LVPWD(mm) | LVM(g) | LVMI(g/m2) |
---|---|---|---|---|---|---|
对照组 | 209 | 44.99±3.24 | 9.71±1.37 | 9.06±0.92 | 142.18±30.63 | 87.71±17.09 |
超重高血压组 | 210 | 46.91±3.45a | 10.29±1.31a | 9.56±0.99a | 163.72±31.89a | 90.16±18.02a |
肥胖高血压组 | 206 | 47.99±3.97ab | 10.54±1.29ab | 9.80±1.04ab | 176.27±39.00ab | 92.36±16.56a |
F值 | 37.813 | 21.557 | 30.863 | 53.399 | 5.681 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.004 |
Table 3 Comparison of echocardiographic indexes among three groups
组别 | 例数 | LVEDd(mm) | IVST(mm) | LVPWD(mm) | LVM(g) | LVMI(g/m2) |
---|---|---|---|---|---|---|
对照组 | 209 | 44.99±3.24 | 9.71±1.37 | 9.06±0.92 | 142.18±30.63 | 87.71±17.09 |
超重高血压组 | 210 | 46.91±3.45a | 10.29±1.31a | 9.56±0.99a | 163.72±31.89a | 90.16±18.02a |
肥胖高血压组 | 206 | 47.99±3.97ab | 10.54±1.29ab | 9.80±1.04ab | 176.27±39.00ab | 92.36±16.56a |
F值 | 37.813 | 21.557 | 30.863 | 53.399 | 5.681 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.004 |
[1] |
|
[2] |
中华医学会心血管病学分会高血压学组. 肥胖相关性高血压管理的中国专家共识[J]. 中华心血管病杂志,2016,44(3):212-219. DOI:10.3760/cma.j.issn.0253-3758.2016.03.006.
|
[3] |
中华医学会心血管病学分会,中国康复医学会心肺预防与康复专业委员会,中华心血管病杂志编辑委员会. 心肺运动试验临床规范应用中国专家共识[J]. 中华心血管病杂志,2022,50(10):973-986. DOI:10.3760/cma.j.cn112148-20220316-00180.
|
[4] |
中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压病学分会,等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志(中英文),2024,32(7):603-700. DOI:10.16439/j.issn.1673-7245.2024.07.002.
|
[5] |
中华医学会心血管病学分会高血压学组. 肥胖相关性高血压管理的中国专家共识[J]. 中华心血管病杂志,2016,44(3):212-219. DOI:10.3760/cma.j.issn.0253-3758.2016.03.006.
|
[6] |
赵平,李冰,刘迎双,等. 非杓型高血压患者血清晚期糖基化终末产物水平与左心室结构的关系[J]. 中华高血压杂志,2019,27(5):479-482. DOI:10.16439/j.cnki.1673-7245.2019.05.022.
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
吴可贵. 肥胖性高血压与非肥胖性高血压患者心率变异性对比分析[J]. 中华高血压杂志,2013,21(3):300. DOI:10.16439/j.cnki.1673-7245.2013.03.023.
|
[1] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[2] | HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian. Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions [J]. Chinese General Practice, 2025, 28(24): 2968-2971. |
[3] | WANG Shuang, WU Shufa, LING Yao, TAN Xiwei, CAO Rudai, ZENG Huiting, KONG Danli, DING Yuanlin, YU Haibing. Metabolomics Based Mediating Role of Non-lipid Metabolites in the Relationship between Obesity and Diabetic Retinopathy: a Mendelian Randomization Study [J]. Chinese General Practice, 2025, 28(21): 2625-2634. |
[4] | LIANG Hengmiao, HUANG Sizhe, CHEN Yuting, LIU Ce, WANG Huijun, DU Qingfeng. A Retrospective Analysis of the Association between Serum Uric Acid Levels and Insulin Resistance Degrees in Individuals Undergoing Health Examination [J]. Chinese General Practice, 2025, 28(21): 2635-2642. |
[5] | JIN Yan, YANG Yang, WANG Lulu, ZHENG Qingwan, LI Xinyan, ZHANG Ning. Effects of Exercise Training after Bariatric Surgery on Cardiopulmonary Function in Patients with Type 2 Diabetes Mellitus and Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(21): 2611-2617. |
[6] | LI Chunxian, LIU Annuo. Study on the Effect and Predictive Value of Obesity and Lipid-related Indices on Metabolic Syndrome in Adults [J]. Chinese General Practice, 2025, 28(21): 2595-2603. |
[7] | HAO Aihua, ZENG Ziying, JIN Aiqiong, TANG Lingling, ZHENG Zique, MA Jingtai, ZHAO Jianguo, ZENG Weilin, XIAO Jianpeng, NIE Hui, YANG Ying. Analysis of Factors Influencing Avoidable Hospitalization for Elderly Hypertensive Patients [J]. Chinese General Practice, 2025, 28(19): 2370-2375. |
[8] | WANG Zhijun, ZHANG Shibo, LIU Jie, LI Dongqi, ZHENG Meijia, ZHOU Jianzhi. Correlation Analysis between TyG-BMI Index and Nocturnal Hypertension in Patients with Hypertension [J]. Chinese General Practice, 2025, 28(18): 2212-2221. |
[9] | PAN Yaojia, FU Fanglin, HAN Zheng, SUN Meng, GU Huaicong, WANG Weiqiang. Correlation of the Type of Obesity with the Cardiometabolic Multimorbidity: a Study in Male and Female Middle-aged Residents in Anhui Province [J]. Chinese General Practice, 2025, 28(18): 2285-2293. |
[10] | ZHANG Zhidong, JIN Hua, HU Jihong, JIANG Lu, WANG Li, LONG Kaichong, ZHANG Ronghua. Analysis and Prediction of the Incidence and Mortality Trends of Hypertensive Nephropathy in China from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(18): 2262-2269. |
[11] | HE Yan, CUI Saixian, HU Yang, NI Qing, GAN Lulu, LIU Qian, DAI Anni, LIU Shijie, YANG Li. Influencing Factors on Urinary Sodium Excretion in Patients with Obstructive Sleep Apnea-Associated Hypertension [J]. Chinese General Practice, 2025, 28(18): 2222-2227. |
[12] | LYU Lulu, ZHU Wanjie, XIAO Mingyang, LI Yike, ZHANG Juan. Correlation Analysis of the Circadian Rhythmicity of Blood Pressure with Ox-LDL/β2GPI Complex and Carotid Atherosclerosis in Patients with Essential Hypertension [J]. Chinese General Practice, 2025, 28(18): 2228-2233. |
[13] | MEI Jingyan, CHEN Min, ZHANG Lieqiang, PAN Yunxi, WANG Xin, ZHAO Xiaodeng, ZHAN Wei, LIU Tao, WANG Yiying. Association between Cumulative Lipid Accumulation Index and Hypertension: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(18): 2205-2211. |
[14] | WANG Biqing, ZHANG Ping, YANG Hongxia, WANG Qian, JU Chunxiao, ZHAO Junnan, MEI Jun, ZHANG Ying, XU Fengqin. Meta-analysis of Prevalence and Development Trend of Mild Cognitive Impairment in Elderly Hypertensive Patients in China [J]. Chinese General Practice, 2025, 28(17): 2186-2192. |
[15] | HE Ting, LI Jia, TAN Wenbin. Research Progress of Circulatory System Diseases and Secondary Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2101-2112. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||